ExeVir Bio Appoints Michel Kazatchkine and Stef Heylen to the Board of Directors ...Middle East

PR Newswire - News
GHENT, Belgium, Nov. 3, 2020 /PRNewswire/ -- ExeVir, which is developing nanobody therapies providing broad protection against viral infections, including a lead candidate for coronaviruses, today announced that Michel Kazatchkine and Stef Heylen have been appointed to the Board. Both...

Read More Details
Finally We wish PressBee provided you with enough information of ( ExeVir Bio Appoints Michel Kazatchkine and Stef Heylen to the Board of Directors )

Apple Storegoogle play

Also on site :